Clinical and research ethics as moral strangers

Area of Science:

• Clinical Research Ethics
• Biomedical Research
• Patient Welfare

Background:

• The ethics of clinical care are often substituted for research ethics in patient recruitment.
• The distinction between therapeutic and non-therapeutic studies is disregarded, risking patient safety.
• Investigators may prioritize scientific purity over patient benefits, using placebos despite risks.

Purpose of the Study:

• To critique the ethical frameworks that subordinate patient care to research objectives.
• To advocate for the primacy of patient well-being in clinical trial subject recruitment.
• To re-evaluate the use of placebos and establish ethical standards for control groups.

Main Methods:

• Analysis of current ethical debates in clinical research.
• Examination of the concept of equipoise and its implications for trial design.
• Review of World Medical Association's stance on placebos in randomized trials.

Main Results:

• Current ethical practices risk exploiting non-competent patients in research.
• The pursuit of scientific purity can lead to increased risks for patient-subjects.
• Equipoise, while curbing redundant research, necessitates trials when equivalence is questioned.

Conclusions:

• Clinical ethics must fully encompass research ethics for patient protection.
• Placebos and sub-medication should be used sparingly in control groups.
• Best existing therapy should serve as the control in trials of new agents.